Philip Murphy

Philip Murphy is an accomplished professional in commercial and medical strategy, currently serving as Associate Director of Oncology at Gilead Sciences. With a robust background in healthcare innovation, Philip has held various significant roles, including Associate Director of Medical Affairs at MSD and Oncology Business Unit Director at BeiGene. Philip's experience encompasses work in pharmacovigilance, clinical trials, and team leadership across multiple organizations, contributing to improved healthcare outcomes and market strategies. Philip is also pursuing advanced education, including a PhD in Medicine and Health from University College Cork and a post-graduate certificate from the University of Otago.